POMT2 and breast carcinoma: A concomitant improved relapse free survival in breast cancer patients with increased expression of POMT2 (Fig. 7C), PMEPA1 (Fig. 7D) and SUMF1 (Fig. 7F) indicated their tumor suppressive behavior.